Jeanne Tie

The predictive value of PET/CT for distant recurrences in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy

Joseph C Kong, Jennifer Ryan, Timothy Akhurst, Samuel Y Ngan, Michael Michael, Jeanne Tie, Satish K Warrier, Alexander G Heriot

Journal article  |  2021  |  JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY

INTRODUCTION: It is well recognized that pathological complete response (pCR) for locally advanced rectal cancer after neoadjuvant..

MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG)

Ho Wai Derrick Siu, Niall Tebbutt, Lorraine Chantrill, Chris Karapetis, Christopher Steer, Kate Wilson, David Espinoza, Lisa Bailey, Sonia Yip, Jeff Cuff, Nick Pavlakis, Subotheni Thavaneswaran, Karen Briscoe, Ratnesh Srivastav, Jennifer Shannon, Eva Segelov, Jeannie Tie, Susan Caird, Alessandra Francesconi, Timothy Price, et al.

Journal article  |  2021  |  BMC CANCER

BACKGROUND: Doublet chemotherapy in combination with a biologic agent has been a standard of care in patients with metastatic colo..

Clinical characteristics and outcomes of patients with oligometastatic colorectal cancer treated with curative intent

Andrew Parsonson, Katharine Kline, Annette Tognela, Aflah Roohullah, Vanessa Wong, Sumitra Ananda, Rachel Wong, Michael Jefford, Jeanne Tie, Adnan Khattak, Prasad Cooray, Shehara Mendis, Jeremy Shapiro, Grace Gard, Julie Johns, Peter Gibbs, Stephanie Lim

Conference Proceedings  |  2021  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Double or nothing? Choice of first-line chemotherapy in a real world metastatic colorectal cancer cohort results from the TRACC registry

Catherine Dunn, Jeanne Tie, Rachel Wong, Suzanne Kosimider, Kathryn Field, Matthew Burge, Yat Hang To, Jeremy Shapiro, Wei Hong, Ross Jennens, Phillip Parente, Susan Caird, Margaret Lee, Belinda Lee, Javier Torres, Azim Jalali, Louise Nott, Peter Gibbs

Conference Proceedings  |  2021  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Real-world outcomes for neoadjuvant capecitabine versus infusional 5-fluorouracil in the treatment of locally advanced rectal cancer

Matthew Loft, Hui-Li Wong, Suzanne Kosmider, Margaret Lee, Jeanne Tie, Rachel Wong, Ian T Jones, Matthew Croxford, Malcolm Steel, Ian Faragher, Mario Guerrieri, Michael Christie, Peter Gibbs

Journal article  |  2021  |  INTERNAL MEDICINE JOURNAL

BACKGROUND: Neoadjuvant chemoradiation therapy is standard-of-care treatment for locally advanced rectal cancer (LARC). A patholog..

Reply to: Does Total Neoadjuvant Treatment Improve Overall Survival in Rectal Cancer? No, It Does Not

Joseph C Kong, Sam Ngan, Jeanne Tie, Alexander G Heriot

Journal article  |  2021  |  ANNALS OF SURGICAL ONCOLOGY

Characterization of KRAS mutation variants and prevalence of KRAS-G12C in gastrointestinal malignancies

M Salem, S El-Refai, W Sha, A Grothey, A Puccini, T George, J Hwang, K Kadakia, L Musselwhite, E Van Cutsem, J Tabernero, J Tie

Conference Proceedings  |  2021  |  ANNALS OF ONCOLOGY

Treatment and Outcomes of Oligometastatic Colorectal Cancer Limited to Lymph Node Metastases.

Vinod Kalapurackal Mathai, Soe Yu Aung, Vanessa Wong, Catherine Dunn, Jeremy Shapiro, Azim Jalali, Rachel Wong, Margaret Lee, Jeanne Tie, Sumitra Ananda, Suzanne Kosmider, Stephanie H Lim, Susan Caird, Matthew Burge, Andrew Dean, Peter Gibbs, Louise Nott

Journal article  |  2021  |  Clin Colorectal Cancer

INTRODUCTION: The optimal management of isolated distant lymph node metastases (IDLNM) from a colorectal primary, is not clearly e..

Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal Cancer

Yat Hang To, Koen Degeling, Suzanne Kosmider, Rachel Wong, Margaret Lee, Catherine Dunn, Grace Gard, Azim Jalali, Vanessa Wong, Maarten IJzerman, Peter Gibbs, Jeanne Tie

Journal article  |  2021  |  PHARMACOECONOMICS

BACKGROUND AND OBJECTIVE: Substantial adjuvant chemotherapy (AC) overtreatment for stage II colorectal cancer results in a health ..

Landscape of KRASG12C, associated genomic alterations, and interrelation with immuno-oncology (IO) biomarkers.

Mohamed E Salem, Sherif El-Refai, Wei Sha, Axel Grothey, Alberto Puccini, Thomas J George, Jimmy J Hwang, Laura W Musselwhite, David King, Kunal C Kadakia, Derek Raghavan, Eric Van Cutsem, Josep Tabernero, Jeanne Tie

Journal article  |  2021  |  Journal of Clinical Oncology

3127 Background: Sotorasib has shown promising activity in cancer patients (pts) specifically harboring the KRASG12C mutation. Re..